{
  "abstract": "Capgras syndrome, a delusional misidentification syndrome characterized by the belief that a close relative or friend has been replaced by an identical imposter, is a rare phenomenon often associated with psychotic disorders. Here, we present a case of a male in his early 80s with Lewy body dementia (LBD) who developed Capgras syndrome. Despite initial challenges in management, including thought blocking and word-finding difficulty, the patient experienced complete resolution of symptoms following treatment with rivastigmine, a cholinesterase inhibitor, commonly used in major neurocognitive disorders. This case highlights the potential efficacy of cholinesterase inhibitors in alleviating psychotic symptoms associated with Capgras syndrome, particularly in individuals with LBD.",
  "authors": [
    {
      "affiliations": [
        "Department of Psychiatry and Behavioral Sciences, Cleveland Clinic Akron General, Akron, Ohio, USA"
      ],
      "name": "Rameez Sultan"
    },
    {
      "affiliations": [
        "Department of Psychiatry and Behavioral Sciences, Cleveland Clinic Akron General, Akron, Ohio, USA"
      ],
      "name": "Rachida Bouhenni"
    },
    {
      "affiliations": [
        "Department of Psychiatry and Behavioral Sciences, Cleveland Clinic Akron General, Akron, Ohio, USA"
      ],
      "name": "Jonathan Sasse"
    },
    {
      "affiliations": [
        "Department of Psychiatry and Behavioral Sciences, Cleveland Clinic Akron General, Akron, Ohio, USA"
      ],
      "name": "Silpa Balachandran"
    }
  ],
  "title": "Successful resolution of Capgras syndrome with rivastigmine treatment in Lewy body dementia",
  "uid": "80dcc19a-efdc-5b90-a101-fa92af85a56b"
}